Nkcfo LLC

SEC CIK: 0001757282
Latest filing: Aug 13, 2026

SEC filings (opens in a new tab)

CRSP holding history

CRISPR Therapeutics AG in every 13F filed by Nkcfo LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRSP overview All 13F holders of CRSP Full Q2 2026 holdings

Shares (Q4 2023): 0; Sold out in Q4 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q2 2023

Holdings of CRSP by Nkcfo LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2023	0	$0	0.0%	−1,075−100.0%	Sold out	Holders
Q3 2023	1,075	$49.0K	<0.1%	00.0%	Unchanged	Holders
Q2 2023	1,075	$60.0K	<0.1%	+1,075	New	Holders